What should you know about tofacitinib and Crohn's disease?

Crohn's disease is an inflammatory bowel condition that can cause diarrhoea, abdominal pain, tiredness, weight change, and periods of flare and remission. Tofacitinib affects immune signalling and is used for selected inflammatory conditions, but its role in Crohn's disease is not the same as an established treatment for every patient. A gastroenterology team considers the diagnosis, previous medicines, infection history, clotting and cardiovascular risks, pregnancy plans, and vaccination status before recommending an immune-modifying medicine. Abdominal pain or diarrhoea can also signal infection or another complication, so symptoms should be interpreted in context.

Discuss the option at a GP consultation or with your gastroenterologist, and provide a complete list of medicines, supplements, allergies, infections, and previous treatment responses. Do not share tablets or alter the dose. Your clinician may arrange a blood test and other checks before and during treatment, looking for blood-count, liver, or cholesterol changes and signs that treatment needs adjustment. Ask which vaccines should be completed first and how to handle a missed dose. Report new infection symptoms promptly and check before taking a new medicine.

Contact your clinical team promptly for fever, persistent cough, painful urination, unusual sores, or other infection symptoms while taking an immune-modifying medicine. Seek urgent care for severe abdominal pain, a swollen abdomen, repeated vomiting, heavy rectal bleeding, black stools, sudden chest pain, breathlessness, or one-sided leg swelling. These symptoms can need immediate assessment and should not be managed by changing treatment alone.

What is the goal of this medicine for my Crohn's disease, and what alternatives fit my history? Which blood tests and infection checks are needed? What symptoms should make me pause, continue, or urgently seek advice? How will we judge whether the treatment is helping?